Targeting USP2 regulation of VPRBP-mediated degradation of p53 and PD-L1 for cancer therapy

Jingjie Yi(Cancer Genetics (United States)), Wei Gu(Cancer Genetics (United States))
Nature Communications
April 6, 2023
Cited by 35


Related Papers